Brushing aside concerns of the US on India's IPR regime, the government on May 13 said its intellectual property rights laws are legal-equitable and WTO-compliant.
Having compulsory licences for pharmaceutical companies has been a hot topic of discussion since almost the past one year. However, sources in the Department of Industrial Policy and Promotion (DIPP) have said that there won't be any additional guidelines.